Translation of "randomization" to Danish language:


  Dictionary English-Danish

Randomization - translation :

  Examples (External sources, not reviewed)

Randomization of Floyd Steinberg
Tilfældiggørelse af Floyd Steinberg
Time from randomization (month)
Tid fra randomisering (måned) (måned) Tid fra randomisering (month) Time from randomization
Time (months) from Randomization at risk
Tid (måneder) fra randomisering antal med risiko
In 1899, this was the period from randomization to 100 days post randomization in 316 it was the period from the baseline day to 111 days post baseline. d
I 1899, var dette perioden fra randomisering til 100 dage efter randomisering i 316 var det perioden fra baseline dagen til 111 dage efter baseline. d
Patients received low dose acetylsalicylic acid prior to randomization and throughout the two CABG surgery studies.
Patienterne fik lav dosis acetylsalicylsyre forud for randomisering og gennem begge de 2 CABG undersøgelser.
A key secondary endpoint was the incidence of proven probable IFIs at 100 days post randomization.
Et andet vigtigt endpoint var forekomsten af bevist sandsynlig IFIs ved 100 dages post randomisering.
Randomization was stratified by low dose ASA use (24 of patients in the overall study population) and age.
Randomiseringen var stratificeret i forhold til brugen af lavdosis acetylsalicylsyre (24 af patienterne i hele studiepopulationen) og alder.
Studies I, II, III, and V required patients to have at least 12 tender and 10 swollen joints at randomization.
I studie I, II, III og V skulle patienterne have mindst 12 ømme og 10 hævede led ved randomisering.
The primary efficacy parameter of the trial was overall survival, defined as the time from randomization to death from any cause.
Den primære effektparameter for studiet var samlet overlevelse, defineret som tid fra randomisering til død, uanset årsag.
The primary efficacy endpoint of the study was TTP, defined as the time from randomization to first documentation of objective tumour progression.
Undersøgelsens primære effektendepunkt var TTP, defineret som tiden fra randomisering til første dokumenterede objektive tumorprogression.
All patients received standard of care analgesia during treatment Patients received low dose acetylsalicylic acid prior to randomization and throughout the two CABG surgery studies.
Patienterne fik lav dosis acetylsalicylsyre forud for randomisering og gennem begge de 2 CABG undersøgelser.
The primary efficacy endpoint was the incidence of proven probable IFIs at 16 weeks post randomization as determined by an independent, blinded external expert panel.
Det primære effekt endpoint var forekomsten af bevist sandsynlig IFIs 16 uger efter randomisering bestemt af et uafhængigt, blindet eksternt ekspert panel.
Prior to randomization, OBT were selected by the investigator based on the patient's prior treatment history, as well as baseline genotypic and phenotypic viral resistance testing.
Før randomisering blev OBT valgt af investigator på baggrund af patientens behandlingsanamnese, samt testning af genotypisk og fænotypisk virusresistens ved baseline.
Patients in Arms A and B were also randomised to receive a GPIIb IIIa inhibitor either upfront at the time of randomization (prior to angiography) or at the time of PCI.
Patienter i arm A og B blev også randomiseret til behandling med GPIIb IIIa inhibitor enten på randomiseringstidspunktet (før angiografi) eller ved
The following factors were pre specified in the statistical analysis plan for inclusion in the model age, time from surgery to randomization, gender, CEA levels at baseline, lymph nodes at baseline, and country.
Alder, tid fra operation til randomisering, køn, CEA værdier ved baseline, lymfeknuder ved baseline samt land.
The following factors were pre specified in the statistical analysis plan for inclusion in the model age, time from surgery to randomization, gender, CEA levels at baseline, lymph nodes at baseline, and country.
Følgende faktorer var præspecificerede i den statistiske analyseplan for inklusion i modellen alder, tid fra operation til randomisering, køn, CEA værdier ved baseline, lymfeknuder ved baseline samt land.
In Study III the efficacy and safety of abatacept were assessed in patients with an inadequate response to a TNF blocking agent, with the TNF blocking agent discontinued prior to randomization other DMARDs were permitted.
Studie III vurderede effekt og sikkerhed af abatacept hos patienter med utilstrækkeligt respons på et TNF hæmmende middel, hvor TNF hæmmeren seponeredes inden randomisering andre DMARD var tilladt.
Prior to randomization, all patients underwent an initial observation period to confirm the need for RBC transfusion and to identify the haemoglobin concentration (the set point ) which would define each patient s haemoglobin stabilization and transfusion outcomes.
Før randomisering gennemgik alle patienter en indledende observationsperiode til bekræftelse af behovet for transfusion af erytrocytter og til fastlæggelse af den hæmoglobinkoncentration (det sætpunkt ), der for hver patient beskriver resultatet hvad angår hæmoglobinstabilisering og transfusion.
In 1899 this was the period from randomization to last dose of study medicinal product plus 7 days in 316 it was the period from first dose to last dose of study medicinal product plus 7 days. c
I 1899 var dette perioden fra randomisering til sidste dosis af undersøgelsens lægemiddel plus 7 dage i 316 var det perioden fra første dosis til sidste dosis af undersøgelsens lægemiddel plus 7 dage. c
Of the patients who lost adequate response after re randomization to placebo who then enrolled into the open label extension trial, 38 (25 66) and 55 (36 66) regained PASI 75 response after 12 and 24 weeks of re treatment, respectively.
38 (25 66) og 55 (36 66) af patienterne, som mistede tilstrækkeligt respons efter genrandomisering til placebo, som derefter blev optaget i det åbne forlængelsesforsøg, genvandt PASI 75 respons efter henholdsvis 12 og 24 ugers genbehandling.
In this study, the majority of patients (79 ) mixed their short acting insulin with NPH insulin immediately prior to injection and 58 of subjects used oral hypoglycemic agents at randomization and were instructed to continue to use them at the same dose.
I dette forsøg blandede størstedelen af patienterne (79 ) deres kortvarigt virkende insulin med NPH insulin lige før injektionen, og 58 af patienterne brugte orale antidiabetika ved randomiseringen og fik besked på fortsat at bruge disse i uændret dosis.
In this study, the majority of patients (79 ) mixed their short acting insulin with NPH insulin immediately prior to injection and 58 of subjects used oral hypoglycemic agents at randomization and were instructed to continue to use them at the same dose.
Race og køn I kontrollerede kliniske forsøg på voksne blev der, ved undergruppeanalyser efter race og køn, ikke påvist forskelle med hensyn til sikkerhed og effekt af insulin glulisin.
In this study, the majority of patients (79 ) mixed their short acting insulin with NPH insulin immediately prior to injection and 58 of subjects used oral hypoglycemic agents at randomization and were instructed to continue to use them at the same dose.
I dette forsøg blandede størstedelen af patienterne (79 ) deres kortvarigt virkende insulin med NPH
Based on Kaplan Meier estimates, the probability of survival up to day 100 after randomization, was significantly higher for posaconazole recipients this survival benefit was demonstrated when the analysis considered all causes of death (P 0.0354) as well as IFI related deaths (P 0.0209).
Baseret på Kaplan Meier estimater, var sandsynligheden for at overleve frem til dag 100 efter randomisering signifikant højere for modtagere af posaconazol denne overlevelsesbenefit blev demonstreret da analysen betragtede alle dødsårsager (P 0, 0354) såvel som IFI relateret død (P 0, 0209).
In a 26 week, placebo controlled trial, followed by a 74 week extension, in manic patients who achieved remission on aripiprazole during a stabilization phase prior to randomization, aripiprazole demonstrated superiority over placebo in preventing bipolar recurrence, primarily in preventing recurrence into mania but failed to demonstrate superiority over placebo in preventing recurrence into depression.
I et 26 ugers, placebokontrolleret forsøg, efterfulgt af en 74 ugers forlængelse, med maniske patienter, som oplevede remission med aripiprazol under en stabiliseringsfase inden randomisering, havde aripiprazol bedre effekt end placebo ved forebyggelse af bipolært recidiv, primært ved at forebygge recidiv af mani, men havde ikke bedre effekt end placebo ved forebyggelse af recidiv af depression.
9 In a 26 week, placebo controlled trial, followed by a 74 week extension, in manic patients who achieved remission on aripiprazole during a stabilization phase prior to randomization, aripiprazole demonstrated superiority over placebo in preventing bipolar recurrence, primarily in preventing recurrence into mania but failed to demonstrate superiority over placebo in preventing recurrence into depression.
I et 26 ugers, placebokontrolleret forsøg, efterfulgt af en 74 ugers forlængelse, med maniske patienter, som oplevede remission med aripiprazol under en stabiliseringsfase inden randomisering, havde aripiprazol bedre effekt end placebo ved forebyggelse af bipolært recidiv, primært ved at forebygge recidiv af mani, men havde ikke bedre effekt end placebo ved forebyggelse af recidiv af depression.
20 In a 26 week, placebo controlled trial, followed by a 74 week extension, in manic patients who achieved remission on aripiprazole during a stabilization phase prior to randomization, aripiprazole demonstrated superiority over placebo in preventing bipolar recurrence, primarily in preventing recurrence into mania but failed to demonstrate superiority over placebo in preventing recurrence into depression.
I et 26 ugers, placebokontrolleret forsøg, efterfulgt af en 74 ugers forlængelse, med maniske patienter, som oplevede remission med aripiprazol under en stabiliseringsfase inden randomisering, havde aripiprazol bedre effekt end placebo ved forebyggelse af bipolært recidiv, primært ved at forebygge recidiv af mani, men havde ikke bedre effekt end placebo ved forebyggelse af recidiv af depression.
31 In a 26 week, placebo controlled trial, followed by a 74 week extension, in manic patients who achieved remission on aripiprazole during a stabilization phase prior to randomization, aripiprazole demonstrated superiority over placebo in preventing bipolar recurrence, primarily in preventing recurrence into mania but failed to demonstrate superiority over placebo in preventing recurrence into depression.
I et 26 ugers, placebokontrolleret forsøg, efterfulgt af en 74 ugers forlængelse, med maniske patienter, som oplevede remission med aripiprazol under en stabiliseringsfase inden randomisering, havde aripiprazol bedre effekt end placebo ved forebyggelse af bipolært recidiv, primært ved at forebygge recidiv af mani, men havde ikke bedre effekt end placebo ved forebyggelse af recidiv af depression.
42 In a 26 week, placebo controlled trial, followed by a 74 week extension, in manic patients who achieved remission on aripiprazole during a stabilization phase prior to randomization, aripiprazole demonstrated superiority over placebo in preventing bipolar recurrence, primarily in preventing recurrence into mania but failed to demonstrate superiority over placebo in preventing recurrence into depression.
I et 26 ugers, placebokontrolleret forsøg, efterfulgt af en 74 ugers forlængelse, med maniske patienter, som oplevede remission med aripiprazol under en stabiliseringsfase inden randomisering, havde aripiprazol bedre effekt end placebo ved forebyggelse af bipolært recidiv, primært ved at forebygge recidiv af mani, men havde ikke bedre effekt end placebo ved forebyggelse af recidiv af depression.
102 In a 26 week, placebo controlled trial, followed by a 74 week extension, in manic patients who achieved remission on aripiprazole during a stabilization phase prior to randomization, aripiprazole demonstrated superiority over placebo in preventing bipolar recurrence, primarily in preventing recurrence into mania but failed to demonstrate superiority over placebo in preventing recurrence into depression.
Aripiprazol havde ikke bedre effekt end placebo ved forebyggelse af recidiv af depression.

 

Related searches: By Randomization - Randomization Was In A Ratio - Memory Randomization - 2-to 1 Randomization - Randomization Was - Randomization Distribution - Group Randomization - Randomization Table -